['prediabetic state', 'obesity']
['dapagliflozin', 'metformin']

        Inclusion Criteria:

          -  HbA1c: from ≥5.7% (39 mmol/mol) to ≤6.4% (47 mmol/mol)

          -  Age: from ≥30 to ≤70 years of age

          -  BMI ≥25 kg/m2

        Exclusion Criteria:

          -  Uncontrolled medical issues including but not limited to cardiovascular pulmonary,
             rheumatologic, hematologic, oncologic, infectious, gastrointestinal or psychiatric
             disease; diabetes or other endocrine disease; immunosuppression;

          -  Current treatment with hormones which affect glucose metabolism;

          -  Current treatment with loop diuretics or thiazolidinediones;

          -  Current treatment with beta blockers or peroral steroids;

          -  Bariatric surgery within the past 2 years;

          -  Impaired renal function defined as an estimated GFR<60 ml/min/1.73m2;

          -  Neurogenic bladder disorders;

          -  Alcohol/drug abuse or in treatment with disulfiram (Antabus) at time of inclusion;

          -  Pregnant or lactating women;

          -  Fertile women not using birth control agents including oral contraceptives, gestagen
             injection, subdermal implants, hormonal vaginal ring, transdermal application, or
             intra-uterine devices;

          -  Allergic to one or more of the medications used in the study;

          -  Concomitant participation in other intervention study;

          -  Unable to understand the informed consent and the study procedures.
      